Dukes Iain D.
SEC insider (Form 3/4/5 filer). CIK 0001681955. Chief Executive Officer at Traws Pharma, Inc. (TRAW) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in NEWTOWN, PA.
Companies Dukes Iain D. has filed insider reports for
- Traws Pharma, Inc. (TRAW): Director, Officer, Chief Executive Officer
- IOVANCE BIOTHERAPEUTICS, INC. (IOVA): Director
- Lomond Therapeutics Holdings, Inc. (NONE): Director, Officer, CEO and Chairman
Dukes Iain D.
CIK: 0001681955
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 9, 2026TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to buy)
274K shares- - Jun 16, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectDeferred Restricted Stock Unit
180.6K shares- - Mar 8, 2026TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to buy)
231.3K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
AwardDirect36.9K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to purchase)
64.8K shares- - Jun 13, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectDeferred Restricted Stock Unit
135.1K shares- - Nov 1, 2024No ticker
Lomond Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
2.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 |  TRAW Traws Pharma, Inc. | Award Stock Option (right to buy) | 274,000 | - | - | Direct |
| Jun 16, 2026 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Deferred Restricted Stock Unit | 180,632 | - | - | Direct |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award Stock Option (right to buy) | 231,336 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award | 36,943 | - | - | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award Stock Option (right to purchase) | 64,839 | - | - | Direct |
| Jun 13, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Deferred Restricted Stock Unit | 135,092 | - | - | Direct |
| Nov 1, 2024 |  No ticker Lomond Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 2,096,667 | - | - | Direct |
1-7 of 7 transactions